All News

GSK announces promising phase 3 trial results for bepirovirsen, a potential treatment for chronic hepatitis B, showing significant functional cure rates.

Episode 6 explores what pharmacists in the diabetes space need to know about outcomes data, safety, and when to escalate LDL-lowering therapy.

In part 3 of our interview with Susan Thomas, RN, she focused on the pharmacist’s role in her organization’s creation of a newly launched women’s health benefit program.

Coping strategies significantly influence psychological health and functional capacity in COPD patients, highlighting the need for effective management.

COVID-19 vaccination significantly reduces long-term mortality risk in chronic obstructive pulmonary disease patients, highlighting its importance for respiratory health and safety.

The administration announces back-to-back approvals for oral therapies used to treat uncomplicated urogenital gonorrhea.

Susan Thomas, RN, CCO at LucyRx, explained the unique offerings from a newly introduced women’s health benefit program launched on January 1, 2026.

Although several vaccines are still being recommended, a variety of those protecting against respiratory viruses and other diseases have been narrowed on child vaccine schedules.

FDA approves denosumab biosimilars Boncresa and Oziltus, enhancing access to affordable treatments for osteoporosis and oncology-related conditions.

Susan Thomas, RN, joined Drug Topics to discuss current gaps in women’s health and how pharmacists are stepping in to counsel in this space more than ever before.

Pharmacists are transforming reproductive health care by expanding their roles in contraception and patient support, despite facing significant barriers.

Orforglipron shows promise in maintaining weight loss for those transitioning from injectable GLP-1 therapies, offering a convenient oral alternative.

FDA approves tradipitant, a treatment for motion sickness, offering effective prevention after 40 years without new options.

As social media’s growth seemingly has no end in sight, pharmacists must be conscious of its potential risks and benefits when using these platforms for either personal or professional use.

In part 3 of our interview, Jennifer Flynn, CPHRM, flips the script on potential harms in using social media and explores how pharmacists can use it to advance their career.

As patients with diabetes and other cardiometabolic conditions take control of their insulin regimens, so too are pharmacists stepping in to help manage new technologies, guidelines, and medications.

Jennifer Flynn, CPHRM, joins Drug Topics to discuss the nuances in social media use for pharmacists and the potential risks they can encounter.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Julissa Gomez, a fourth-year pharmacy student at the University of Illinois Chicago Retzky College of Pharmacy.

Explore the latest insights on team-based care, AI in pharmacy, and innovative PBM models shaping the future of health care in 2025.

Spanning those focused on pneumococcal diseases to continued developments of vaccines against COVID-19, these are the most-read immunization stories from 2025.

Jennifer Flynn, CPHRM, vice president of health care risk management at the Healthcare Provider Service Organization, discusses pharmacists’ roles in patient privacy.

Pharmacy benefit manager reforms and new pain management options reshape the pharmaceutical landscape, enhancing patient access and care in 2025.

With brand-new challenges and opportunities in the GLP-1 space and obesity management as a whole, here are the top developments from the past year.

Marking 5 years since the COVID-19 pandemic forever changed health care in 2020, check out the top 5 COVID-19 stories from 2025.

Pharmacists are expanding their roles in reproductive health, overcoming barriers to provide essential services and improve community care.

Explore the latest advancements in pharmacy, including innovative therapies, cost-saving models, and significant reforms shaping the industry in 2025.

A recent study reveals COVID-19 vaccination significantly reduces severe maternal disease and preterm birth risks during pregnancy.

Discover critical insights on respiratory health, COVID-19 impacts, and vaccination strategies from recent studies and regional policy changes.